Repositorio Dspace

Impella 5.5 Support in Severe Cardiogenic Shock: Outcomes From the First Spanish Multicentre Cohort in Heart Transplant Centres

Mostrar el registro sencillo del ítem

dc.contributor.author Martínez-Comendador, José-Manuel
dc.contributor.author Martín-Gutiérrez, Elio
dc.contributor.author Ortiz-Berbel, Daniel
dc.contributor.author García-Alcalde, Lucía
dc.contributor.author Pedraz-Prieto, Álvaro
dc.contributor.author Muñoz-Guijosa, Christian
dc.contributor.author Martin-López, Carlos-Esteban
dc.contributor.author Urso, Stefano
dc.contributor.author Rabago-Juan-Aracil, Gregorio
dc.contributor.author Cuenca-Castillo, José-Joaquín
dc.contributor.author Pérez-Guillén, Manuel
dc.date.accessioned 2026-09-17T12:13:36Z
dc.date.available 2026-09-17T12:13:36Z
dc.date.issued 2026-05-05
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28105
dc.description.abstract OBJECTIVES: Impella 5.5 is an established temporary mechanical circulatory support (tMCS) device for severe cardiogenic shock. Spain, characterized by high heart transplant activity and increasing use of controlled donation after circulatory death (DCD), provides a relevant setting to evaluate its use and outcomes. We aimed to describe clinical characteristics, trajectories, and outcomes of Impella 5.5 support in the first Spanish multicentre cohort from heart transplant centres. METHODS: Retrospective multicentre observational study including consecutive patients supported with Impella 5.5 in hospitals with active heart transplant programmes. Baseline characteristics, Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile, additional support, complications, support duration, and in-hospital mortality were recorded. Outcomes were analysed across INTERMACS profiles. RESULTS: Ninety-three patients were included (33 INTERMACS 1, 37 INTERMACS 2, 23 INTERMACS 3). Additional support was required in 46%, mainly venoarterial extracorporeal life support (VA-ECLS). Device-related complications were reported as event frequencies. The predominant clinical trajectory was heart transplantation (68.8%), contrasting with international series in which long-term mechanical support and transplantation are more evenly distributed. In-hospital mortality was 43%, with a clear gradient across INTERMACS profiles 1-3 (60.6%, 37.8%, and 26.1%, respectively; P = .013). Mean support duration was 16 days, and more than one-third of transplants were from controlled DCD donors. CONCLUSIONS: Impella 5.5 was used as tMCS in severe cardiogenic shock and was predominantly associated with heart transplantation in a transplant-oriented healthcare system. Outcomes were closely associated with INTERMACS profile, reflecting differences in baseline severity and patient selection. Comparisons with international registries are descriptive only.
dc.language.iso eng
dc.publisher OXFORD UNIV PRESS
dc.rights Atribución/Reconocimiento 4.0 Internaciona
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Humans
dc.subject.mesh Shock, Cardiogenic/mortality/therapy/physiopathology/diagnosis
dc.subject.mesh Heart-Assist Devices
dc.subject.mesh Heart Transplantation/adverse effects/mortality
dc.subject.mesh Retrospective Studies
dc.subject.mesh Female
dc.subject.mesh Spain
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Hospital Mortality
dc.subject.mesh Treatment Outcome
dc.subject.mesh Severity of Illness Index
dc.subject.mesh Aged
dc.subject.mesh Adult
dc.subject.mesh Registries
dc.subject.mesh Time Factors
dc.title Impella 5.5 Support in Severe Cardiogenic Shock: Outcomes From the First Spanish Multicentre Cohort in Heart Transplant Centres
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 42127978
dc.relation.publisherversion https://academic.oup.com/icvts/article/doi/10.1093/icvts/ivag137/8677618
dc.type.version info:eu-repo/semantics/publishedVersion 
dc.identifier.doi 10.1093/icvts/ivag137
dc.journal.title INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY
dc.identifier.essn 2753-670X


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internaciona Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internaciona

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta